118 related articles for article (PubMed ID: 9468029)
1. Synthesis and 5-HT-3 receptor binding of 2- and 3-(halo)alkoxyl substituted (S)-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chlorobenzamides as potential radioligands.
Hewlett WA; Schmidt DE; Mason NS; Trivedi BL; Ebert MH; de Paulis T
Nucl Med Biol; 1998 Feb; 25(2):141-53. PubMed ID: 9468029
[TBL] [Abstract][Full Text] [Related]
2. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
[TBL] [Abstract][Full Text] [Related]
3. Characterization of desamino-5-[125I]iodo-3-methoxy-zacopride ([125I]MIZAC) binding to 5-HT3 receptors in the rat brain.
Hewlett WA; Fridman S; Trivedi BL; Schmidt DE; de Paulis T; Ebert MH
Prog Neuropsychopharmacol Biol Psychiatry; 1998 Feb; 22(2):397-410. PubMed ID: 9608609
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and radiolabeling of (S)-4-amino-5-iodo-2-methoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide, the active enantiomer of [125I]iodozacopride, and re-evaluation of its 5-HT3 receptor affinity.
Hewlett WA; de Paulis T; Mason NS; Schmidt DE; Trivedi BL; Zhang ZJ; Ebert MH
Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2079-84. PubMed ID: 9433779
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biodistribution of iodine-125-labeled 1-azabicyclo[2.2.2]oct-3-yl alpha-hydroxy-alpha-(1-iodo-1-propen-3-yl)-alpha-phenylacetate. A new ligand for the potential imaging of muscarinic receptors by single photon emission computed tomography.
McPherson DW; DeHaven-Hudkins DL; Callahan AP; Knapp FF
J Med Chem; 1993 Apr; 36(7):848-54. PubMed ID: 8464039
[TBL] [Abstract][Full Text] [Related]
6. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of (11)C-labeled (S)-N-[[1-(2-phenylethyl) pyrrolidin-2-yl]methyl]-3-methylthiobenzamide as a PET 5-HT(1A) receptor ligand.
Fujio M; Nagata S; Kawamura K; Sugiyama N; Tanaka H; Uno K; Ishiwata K
Nucl Med Biol; 2002 Aug; 29(6):657-63. PubMed ID: 12234590
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
[TBL] [Abstract][Full Text] [Related]
11. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands.
Zhuang ZP; Kung MP; Mu M; Kung HF
J Med Chem; 1998 Jan; 41(2):157-66. PubMed ID: 9457239
[TBL] [Abstract][Full Text] [Related]
12. Preparation and properties of (R)-(-)-1-azabicyclo[2.2.2]oct-3-yl- (R)-(+)-alpha-hydroxy-alpha-(4-[125I]iodophenyl)-alpha-phenyl acetate and (R)-(-)-1-azabicyclo[2.2.2]oct-3-yl-(S)-(-)-alpha-hydroxy-alpha- (4-[125I]iodophenyl)-alpha-phenyl acetate as potential radiopharmaceuticals.
Cohen VI; Rzeszotarski WJ; Gibson RE; Fan LH; Reba RC
J Pharm Sci; 1989 Oct; 78(10):833-6. PubMed ID: 2600789
[TBL] [Abstract][Full Text] [Related]
13. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
[TBL] [Abstract][Full Text] [Related]
14. Discrimination in 5-HT(3) receptor binding in murine brain and cultured cell preparations.
Zhang ZJ; Trivedi BL; de Paulis T; Schmidt DE; Hewlett WA
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):123-32. PubMed ID: 11819030
[TBL] [Abstract][Full Text] [Related]
15. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
de Paulis T; Janowsky A; Kessler RM; Clanton JA; Smith HE
J Med Chem; 1988 Oct; 31(10):2027-33. PubMed ID: 3172140
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of [125I]-(S)-iodozacopride, a high affinity radioligand for 5HT3 receptors.
Gehlert DR; Schober DA; Gackenheimer SL; Mais DE; Ladouceur G; Robertson DW
Neurochem Int; 1993 Oct; 23(4):373-83. PubMed ID: 8220179
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 1-azabicyclo[2.2.2]oct-3-yl alpha-fluoroalkyl-alpha-hydroxy-alpha-phenylacetates as potential ligands for the study of muscarinic receptor density by positron emission tomography.
Luo H; Hasan A; Sood V; McRee RC; Zeeberg B; Reba RC; McPherson DW; Knapp FF
Nucl Med Biol; 1996 Apr; 23(3):267-76. PubMed ID: 8782236
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological characterization of 4-[125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity sigma receptor ligand for potential imaging of breast cancer.
John CS; Vilner BJ; Gulden ME; Efange SM; Langason RB; Moody TW; Bowen WD
Cancer Res; 1995 Jul; 55(14):3022-7. PubMed ID: 7606722
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, radiolabeling, and in vivo evaluation of carbon-11 labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-methoxybenzamide, a potential positron emission tomography tracer for the dopamine D(4) receptors.
Lacivita E; De Giorgio P; Lee IT; Rodeheaver SI; Weiss BA; Fracasso C; Caccia S; Berardi F; Perrone R; Zhang MR; Maeda J; Higuchi M; Suhara T; Schetz JA; Leopoldo M
J Med Chem; 2010 Oct; 53(20):7344-55. PubMed ID: 20873719
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vitro binding profile and biodistribution of a 125I-labeled N-benzyl pyrrolidinyl benzamide derivative: a potential radioligand for mapping dopamine D2 receptors.
Saji H; Tanahashi K; Kinoshita T; Iida Y; Magata Y; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):121-7. PubMed ID: 8868283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
